Skip to main content

Table 4 QLQ-TC26 scores in patients with previous metastatic or non-metastatic disease post-treatment

From: International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26

  Previous metastatic disease
N = 21
Previous non-metastatic disease
N = 157
  
EORTC QLQ-TC26 Mean SD Mean SD t-statistic p-value
Treatment Side Effects 15.3 21.8 8.2 12.3 1.461 0.158
Treatment Satisfaction 78.7 31.2 92.7 19.7 −1.860 0.079
Future Perspective 65.9 26.1 67.3 26.6 −0.233 0.816
Family Problems 30.0 34.0 21.4 29.0 1.218 0.225
Infertility 30.2 31.5 29.9 33.8 0.029 0.977
Communication 71.4 26.9 85.0 22.8 −2.510 0.013*
Body Image Problems 22.2 32.2 11.3 20.5 1.520 0.143
Sexual Activity 50.0 26.4 67.9 26.3 −2.932 0.004**
Sexual Functioning 76.9 33.9 87.7 21.8 −1.325 0.201
Job Education problems 22.2 35.5 10.0 23.7 1.536 0.139
Physical limitations 22.2 35.5 13.0 24.4 1.161 0.258
Sexual Enjoyment 59.3 32.5 81.3 24.3 −3.503 0.001**
Testicular Implant Satisfaction 66.7 38.5 66.7 32.9 < 0.001 1.000
  1. Note. *p <.05, **p <.01